These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38199914)

  • 41. Role of
    Dolci C; Ceppi L; Guerra L; Crivellaro C; Lamanna M; Adorni M; Elisei F; Bonazzi CM; Sina F; Fruscio R; Messa C
    Int J Gynecol Cancer; 2019 Oct; 29(8):1298-1303. PubMed ID: 31366569
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Carbon-11-Labeled Methionine PET/CT in Patients With FDG-Occult Multiple Myeloma: A Prospective Pilot Study.
    Wang Y; Yee A; Bernstein Z; O'Donnell E; Raje N; Mahmood U
    AJR Am J Roentgenol; 2023 Apr; 220(4):578-579. PubMed ID: 36382911
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The lung cancers: staging and response, CT,
    Owens C; Hindocha S; Lee R; Millard T; Sharma B
    Br J Radiol; 2023 Aug; 96(1148):20220339. PubMed ID: 37097296
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Whole body MRI with Diffusion Weighted Imaging versus 18F-fluorodeoxyglucose-PET/CT in the staging of lymphomas.
    Maccioni F; Alfieri G; Assanto GM; Mattone M; Gentiloni Silveri G; Viola F; De Maio A; Frantellizzi V; Di Rocco A; De Vincentis G; Pulsoni A; Martelli M; Catalano C
    Radiol Med; 2023 May; 128(5):556-564. PubMed ID: 37145214
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The impact of
    Elmanzalawy A; Vali R; Chavhan GB; Gupta AA; Omarkhail Y; Amirabadi A; Shammas A
    Pediatr Radiol; 2020 Feb; 50(2):252-260. PubMed ID: 31628508
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Whole-body 18F-FDG PET/CT in patients with multiple myeloma.
    de Bonilla Damiá A; Fernández López R; Paz Coll A; Borrego Dorado I
    Med Clin (Barc); 2017 Apr; 148(7):e37. PubMed ID: 27450173
    [No Abstract]   [Full Text] [Related]  

  • 47. Update on advances in molecular PET in urological oncology.
    Kitajima K; Yamamoto S; Fukushima K; Minamimoto R; Kamai T; Jadvar H
    Jpn J Radiol; 2016 Jul; 34(7):470-85. PubMed ID: 27222021
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Positron Emission Tomography Imaging in Vasculitis.
    van der Geest KSM; Slijkhuis BGC; Tomelleri A; Gheysens O; Jiemy WF; Piccolo C; Nienhuis P; Sandovici M; Brouwer E; Glaudemans AWJM; Mulder DJ; Slart RHJA
    Cardiol Clin; 2023 May; 41(2):251-265. PubMed ID: 37003681
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of whole-body 18F-FDG PET/CT and PET/MRI for distant metastases in patients with malignant tumors: a meta-analysis.
    Zhang C; Liang Z; Liu W; Zeng X; Mo Y
    BMC Cancer; 2023 Jan; 23(1):37. PubMed ID: 36624425
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fluorodeoxyglucose-PET/Computed Tomography as a Predictor of Prognosis in Multiple Myeloma.
    Nanni C; Zamagni E
    PET Clin; 2019 Jul; 14(3):383-389. PubMed ID: 31084777
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multiple Myeloma Presenting as Disseminated Osteoblastic Lesions With Intense 18F-FDG Uptake on PET/CT.
    Wang Y; Fan Q; Su M
    Clin Nucl Med; 2021 Oct; 46(10):e492-e495. PubMed ID: 33630796
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Different lesions revealed by 18F-FDG PET/CT and 18F-NaF PET/CT in patients with multiple myeloma.
    Xu F; Liu F; Pastakia B
    Clin Nucl Med; 2014 Sep; 39(9):e407-9. PubMed ID: 24217536
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis.
    Machado Medeiros T; Altmayer S; Watte G; Zanon M; Basso Dias A; Henz Concatto N; Hoefel Paes J; Mattiello R; de Souza Santos F; Mohammed TL; Verma N; Hochhegger B
    Eur Radiol; 2020 Jul; 30(7):3641-3649. PubMed ID: 32125513
    [TBL] [Abstract][Full Text] [Related]  

  • 54. What Is the Comparative Ability of 18F-FDG PET/CT, 99mTc-MDP Skeletal Scintigraphy, and Whole-body MRI as a Staging Investigation to Detect Skeletal Metastases in Patients with Osteosarcoma and Ewing Sarcoma?
    Aryal A; Kumar VS; Shamim SA; Gamanagatti S; Khan SA
    Clin Orthop Relat Res; 2021 Aug; 479(8):1768-1779. PubMed ID: 33635285
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma.
    Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
    Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evidence of Clinical Impact Supports a New Petition for Medicare Coverage of 2-[18F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography in the Evaluation of Staphylococcus aureus Bacteremia: A Focused Literature Review and Call to Action.
    Thottacherry E; Cortés-Penfield NW
    Clin Infect Dis; 2022 Oct; 75(8):1457-1461. PubMed ID: 35535794
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 11C-choline vs. 18F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma.
    Nanni C; Zamagni E; Cavo M; Rubello D; Tacchetti P; Pettinato C; Farsad M; Castellucci P; Ambrosini V; Montini GC; Al-Nahhas A; Franchi R; Fanti S
    World J Surg Oncol; 2007 Jun; 5():68. PubMed ID: 17584499
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of 18F-FDG PET/CT and ultrasound in staging of patients with malignant melanoma.
    Weber P; Arnold A; Hohmann J
    Medicine (Baltimore); 2022 Oct; 101(42):e31092. PubMed ID: 36281128
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Present and future role of FDG-PET/CT imaging in the management of head and neck carcinoma.
    Kitajima K; Suenaga Y; Sugimura K
    Jpn J Radiol; 2015 Dec; 33(12):776-89. PubMed ID: 26507982
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in muscle-invasive bladder cancer.
    Einerhand SMH; van Gennep EJ; Mertens LS; Hendricksen K; Donswijk ML; van der Poel HG; van Rhijn BWG
    Curr Opin Urol; 2020 Sep; 30(5):654-664. PubMed ID: 32701719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.